Cas No.: | 519055-63-1 |
Chemical Name: | N-[(5-bromo-2-thienyl)sulfonyl]-2,4-dichloro-benzamide sodium salt |
Synonyms: | LY 573636 sodium |
SMILES: | ClC1=CC(Cl)=C(C=C1)C(=O)NS(=O)(=O)C2SC(Br)=CC=2 |
Formula: | C11H5BrCl2NNaO3S2 |
M.Wt: | 437.09 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Tasisulam (LY 573636) is a small molecule antitumor agent that induces apoptosis via the intrinsic pathway, resulting in cytochrome c release and caspase-dependent cell death; shows antiproliferative effect against a variety of human hematopoietic malignancies, including AML, B-ALL, large B-cell and mantle cell lymphoma cell lines; promotes the recruitment of RBM39 to the CUL4-DCAF15 E3 ubiquitin ligase, leading to RBM39 polyubiquitination and proteasomal degradation; causes aberrant pre-mRNA splicing. Blood Cancer Phase 1 Discontinued |